| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -10.99 M USD | -6.93 M USD | -8.51 M USD | -6.43 M USD | -3.15 M USD |
| Depreciation & Amortization | 132540 USD | 773904 USD | 882177 USD | 654572 USD | 28699 USD |
| Stock-Based Compensation | — | 520830 USD | 963023 USD | 1.01 M USD | 1.20 M USD |
| Capital Expenditures | — | 138804 USD | 698277 USD | 542662 USD | 2.22 M USD |
| Cash Flow from Investing | -187.52 M USD | -1.16 M USD | -698277 USD | -3.12 M USD | -2.34 M USD |
| Cash Flow from Financing | 215.51 M USD | 5.91 M USD | 8.03 M USD | 12.24 M USD | 5.18 M USD |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — |
| Free Cash Flow | — | -7.07 M USD | -9.21 M USD | -6.98 M USD | -5.37 M USD |
Sharps Technology Inc. is a company focused on the design and manufacture of innovative safety syringe products. Its primary function is to enhance patient and healthcare worker safety by reducing the risk of needlestick injuries and improving medication delivery systems. The company's portfolio includes patented products that offer state-of-the-art solutions to obstacles faced in the medical and pharmaceutical sectors. With a commitment to research and development, Sharps Technology Inc. plays a pivotal role in advancing needle safety protocols in health care settings. Operating in a highly regulated industry, the company impacts not only health care facilities but also pharmaceutical companies and government agencies involved in public health and safety. By addressing critical safety concerns within the medical field, Sharps Technology Inc. contributes significantly to the overall improvement of health care delivery systems. Its innovations have market significance as they potentially influence regulatory standards and guide future developments in medical safety equipment.